Screener
Kymera Therapeutics KYMR Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | $737,265 | $871,214 |
| Marketable securities, non-current (Note 4) | 813,901 | 771,158 |
| Property and equipment, net (Note 6) | 39,971 | 43,175 |
| Right-of-use assets, operating leases | 41,100 | 42,351 |
| Other non-current assets | 7,385 | 9,114 |
| Restricted cash | 5,822 | 5,800 |
| Total assets | $1,645,444 | $1,742,812 |
| Liabilities and Stockholders’ Equity |
Item 1. Financial Statements.
FAQ
- What is Kymera Therapeutics's operating lease ROU assets?
- Kymera Therapeutics (KYMR) reported operating lease ROU assets of $41.1M in Q2 2026.
- How has Kymera Therapeutics's operating lease ROU assets changed year-over-year?
- Kymera Therapeutics's operating lease ROU assets decreased by 10.7% year-over-year, from $46.05M to $41.1M.
- What is the long-term trend for Kymera Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Kymera Therapeutics's operating lease ROU assets has grown at a 33.9% compound annual growth rate (CAGR), from $9.85M to $42.35M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Kymera Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude